Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in ...

Novo Nordisk gained approval for Wegovy in China in June, and will initially target Chinese patients willing to pay ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Novo Nordisk's Wegovy launch in China begins in Shanghai at $194 per four-injection pack, significantly cheaper than U.S.

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Novo Nordisk has officially launched its weight loss medication Wegovy in China. This move opens access to over 500 million ...

Lilly weight-loss drugs 2:41 PM UTC Healthcare & Pharmaceuticalscategory Nigeria begins delayed mpox vaccination programme ...

Wegovy, to the Chinese market. The launch, confirmed by the company via Reuters and first reported by Chinese business media Yicai, marks a significant step in Novo Nordisk’s global expansion. With ...